Related content

The effect of glargine versus glimepiride on pancreatic β-cell function in patients with type 2 diabetes uncontrolled on metformin monotherapy: open-label, randomized, controlled study

By Moon Jun   Ha Kyoung   Yoon Ji   Lee Hyoung   Lee Hyun   Won Kyu  

Acta Diabetologica, Vol. 51, Iss. 2, 2014-04 ,pp. : 277-285

Springer Publishing Company

Access to resources Recommend Favorite

Effects of gestational diabetes mellitus on proteins implicated in insulin signaling in human placenta

By Alonso Ana   Del Rey Carmen González   Navarro Ana   Tolivia Jorge   González Celestino G.  

Gynecological Endocrinology, Vol. 22, Iss. 9, 2006-09 ,pp. : 526-535

Informa Healthcare

Access to resources Recommend Favorite

The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients—the EUGENE2 study

By Boesgaard T.   Žilinskaitė J.   Vänttinen M.   Laakso M.   Jansson P.-A.   Hammarstedt A.   Smith U.   Stefan N.   Fritsche A.   Häring H.   Hribal M.   Sesti G.   Zobel D.   Pedersen O.   Hansen T.  

Diabetologia, Vol. 51, Iss. 5, 2008-05 ,pp. : 816-820

Springer Publishing Company

Access to resources Recommend Favorite

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes

By Hermansen K.   Fontaine P.   Kukolja K.   Peterkova V.   Leth G.   Gall M.-A.  

Diabetologia, Vol. 47, Iss. 4, 2004-04 ,pp. : 622-629

Springer Publishing Company

Access to resources Recommend Favorite

Spotlight on Insulin Aspart in Type 1 and 2 Diabetes Mellitus

By Chapman T.M.   Noble S.   Goa K.L.  

Treatments in Endocrinology, Vol. 2, Iss. 1, 2003-01 ,pp. : 71-76

Adis International

Access to resources Recommend Favorite